Literature DB >> 22479925

Evaluation of thermotherapy for the treatment of cutaneous leishmaniasis in Kabul, Afghanistan: a randomized controlled trial.

Najibullah Safi1, Gary D Davis, Mohammed Nadir, Hamida Hamid, Leon L Robert, Alan J Case.   

Abstract

Anthroponotic cutaneous leishmaniasis (CL) is a common cause of ulcerative lesions and disfiguring scarring among children in Afghanistan. Most lesions occur on the face and are commonly caused by the trypanosome protozoan parasite Leishmania tropica, transmitted by the bite of an infected sandfly (Phlebotomus sergenti). This study compared the effectiveness of a single localized treatment with thermotherapy to 5 days of intralesional administration of Glucantime for the treatment of CL. Three hundred and eighty-two patients with CL were randomly assigned to the two treatment groups and followed for 6 months. The cure rate for the thermotherapy group was 82.5%, compared to 74% in the Glucantime group. The authors concluded that a single localized treatment with thermotherapy was more effective than 5 days of intralesional administration of Glucantime. Additionally, thermotherapy was more cost-effective, with fewer side effects, of shorter duration, and with better patient compliance than intralesional Glucantime.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22479925     DOI: 10.7205/milmed-d-11-00161

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  26 in total

Review 1.  Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development.

Authors:  Shyam Sundar; Neha Agrawal; Bhawana Singh
Journal:  Expert Opin Drug Metab Toxicol       Date:  2019-06-17       Impact factor: 4.481

2.  Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015.

Authors:  Adrienne J Showler; Andrea K Boggild
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

Review 3.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-11-17

Review 4.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

Review 5.  Plant-derived compounds in treatment of leishmaniasis.

Authors:  A Oryan
Journal:  Iran J Vet Res       Date:  2015       Impact factor: 1.376

Review 6.  Interventions for Old World cutaneous leishmaniasis.

Authors:  Julio Heras-Mosteiro; Begoña Monge-Maillo; Mariona Pinart; Patricia Lopez Pereira; Ludovic Reveiz; Emely Garcia-Carrasco; Pedro Campuzano Cuadrado; Ana Royuela; Irene Mendez Roman; Rogelio López-Vélez
Journal:  Cochrane Database Syst Rev       Date:  2017-12-01

Review 7.  Heat therapy for cutaneous leishmaniasis: A literature Review.

Authors:  Amir Hossein Siadat; Fariba Iraji; Azadeh Zolfaghari; Sheila Shariat; Safoura Bokaie Jazi
Journal:  J Res Med Sci       Date:  2021-02-27       Impact factor: 1.852

8.  Novel low-cost thermotherapy for cutaneous leishmaniasis in Peru.

Authors:  Braulio M Valencia; David Miller; Richard S Witzig; Andrea K Boggild; Alejandro Llanos-Cuentas
Journal:  PLoS Negl Trop Dis       Date:  2013-05-02

9.  Efficacy of thermotherapy to treat cutaneous leishmaniasis: a meta-analysis of controlled clinical trials.

Authors:  Jaiberth Antonio Cardona-Arias; Iván Darío Vélez; Liliana López-Carvajal
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

10.  Efficacy of Microwave and Infrared Radiation in the Treatment of the Skin Lesions Caused by Leishmania major in an Animal Model.

Authors:  Se Eskandari; A Azimzadeh; M Bahar; Z Safai Naraghi; A Javadi; A Khamesipour; A Miramin Mohamadi
Journal:  Iran J Public Health       Date:  2012-08-31       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.